Renhe Pharmacy Co.,Ltd

¥5.12As of Sun 8 Nov 2026, 12:00 UTC
SZSE:000650Healthcare
Country China
PE (Fwd) •••
TSR 10Y CAGR (1.51%)
Div yield 2.93%
ROE 6.74%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.31
PE TTM 18.62
TSR TTM (15.28%)
Mkt cap ¥7.077B
ROIC 13.67%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥6.59
28.63%
(58.13%)
Buy 10|1|7|5|4
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.05
0.05
0.06
0.06
23.04%
14.40%
22.33%
33.42%
Revenue¥M
368.4
377.5
373.0
367.7
0.63%
4.63%
(1.35%)
(1.53%)
Peers (US$1.061B)
Cap (US$)
PE
1.068B
106.9x
1.064B
18.96x
Capital
TTM
5Y
10Y
Leveragex
1.949
0.715
0.495
EBIT/Intx
1.389
1.313
1.338
Own earn%
155.57
(25.26)
(21.85)
Sh yield%
25.65
9.98
12.17
Owners
Insiders/Inst%
14.78
63.50
Short interest%
2.95
SBC / revenue%
0.80
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
12
Op margin range%
17–21
$1 testx
—
Incr. ROIC%
1